This inventor holds 2 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, US Government as Represented by the Secretary of the Army. Active years: 1997.
Company Filing History:
1 out of 1,217 
1 out of 8,745 
Years Active: 1997
Title: Innovations of Kurt R Klimpel
Introduction
Kurt R Klimpel is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of anthrax toxin fusion proteins. With a total of 2 patents to his name, his work has implications for both medical and biological research.
Latest Patents
Kurt R Klimpel's latest patents focus on anthrax toxin fusion proteins and related methods. The first patent provides a nucleic acid encoding a fusion protein that includes a nucleotide sequence for the anthrax protective antigen (PA) binding domain of the native anthrax lethal factor (LF) protein, along with an activity-inducing domain of a second protein. This invention also includes a method for delivering an activity to a cell, which involves administering a protein that comprises the translocation domain and LF binding domain of the native PA protein. The second patent similarly provides a nucleic acid encoding a fusion protein with comparable components and methods for cellular activity delivery.
Career Highlights
Throughout his career, Kurt R Klimpel has worked with esteemed organizations, including the U.S. Government as represented by the Secretary of the Army and the United States of America as represented by the Department of Health. His work has been pivotal in advancing the understanding and application of anthrax-related proteins.
Collaborations
Kurt R Klimpel has collaborated with notable colleagues such as Stephen H Leppla and Naveen Arora. Their combined expertise has contributed to the success of various projects in the field of biotechnology.
Conclusion
Kurt R Klimpel's innovative work in the development of anthrax toxin fusion proteins showcases his significant contributions to biotechnology and medical research. His patents reflect a commitment to advancing scientific knowledge and practical applications in the field.